Piu Medical SpA (MIL:PMED) EBIT: € Mil (TTM As of Jun. 2025)


MIL:PMED Piu Medical SpA MIL:PMED
13 GF Score
Price €5.25
! 4 Warning Signs
View Full Analysis

What is Piu Medical SpA EBIT?

Piu Medical SpA MIL:PMED 13 EBIT is € Mil as of Jun. 2025. GuruFocus rates MIL:PMED with a GF Score™ of 13/100. The stock has 4 warning signs investors should review.

Piu Medical SpA's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2025 was €0.60 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Piu Medical SpA's annualized ROC % for the quarter that ended in Jun. 2025 was 0.94%. Piu Medical SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was 20.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Piu Medical SpA  (MIL:PMED) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Piu Medical SpA's annualized ROC % for the quarter that ended in Jun. 2025 is calculated as:

ROC % (Q: Jun. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Jun. 2025 ))/ count )
=1.342 * ( 1 - 73.9% )/( (37.599 + 37.236)/ 2 )
=0.350262/37.4175
=0.94 %

where

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=37.837 - 4.386 - ( 0.05 - max(0, 8.658 - 4.51+0.05))
=37.599

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=37.56 - 4.435 - ( 0.05 - max(0, 8.691 - 4.58+0.05))
=37.236

Note: The Operating Income data used here is two times the semi-annual (Jun. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Piu Medical SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Jun. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1.208/( ( (6.244 + max(-0.077999999999999, 0)) + (5.729 + max(-0.092000000000001, 0)) )/ 2 )
=1.208/( ( 6.244 + 5.729 )/ 2 )
=1.208/5.9865
=20.18 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.63 + 2.202 + 1.513) - (4.386 + 0 + 0.036999999999999)
=-0.077999999999999

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.609 + 2.375 + 1.379) - (4.435 + 0 + 0.020000000000001)
=-0.092000000000001

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Piu Medical SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2025 )
=/29.067
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piu Medical SpA EBIT Related Terms

Piu Medical SpA EBIT Historical Data

* Premium members only.

The historical data trend for Piu Medical SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piu Medical SpA EBIT Chart

Piu Medical SpA Annual Data
Trend Dec23 Dec24 Dec25
EBIT
2.66 2.37 0.14

Piu Medical SpA Semi-Annual Data
Dec23 Dec24 Jun25 Dec25
EBIT 0.00 0.00 0.60 -0.47

Piu Medical SpA EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Piu Medical SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piu Medical SpA EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Piu Medical SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Piu Medical SpA's EV-to-EBIT falls into.


MIL:PMED
13GF Score
Piu Medical SpA MIL:PMED
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Piu Medical SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was € Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of € Mil mean?
Piu Medical SpA (MIL:PMED) has a EBIT of € Mil as of Jun. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Piu Medical SpA.
Is Piu Medical SpA's EBIT too high?
Piu Medical SpA's current EBIT is € Mil. Overall, Piu Medical SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's EBIT compare to competitors?
Piu Medical SpA's EBIT of € Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Piu Medical SpA. Piu Medical SpA's current EBIT is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (MIL:PMED) has a current EBIT of € Mil. The current EBIT is € Mil. Piu Medical SpA's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Piu Medical SpA (MIL:PMED), the current EBIT is € Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Piu Medical SpA Business Description

Address Viale LombardiA 62, Castronno, ITA, IT-21040
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
13GF Score

Get the complete analysis for MIL:PMED

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.25
Price